期刊
ARCHIVES OF MEDICAL RESEARCH
卷 43, 期 7, 页码 514-521出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.arcmed.2012.09.007
关键词
MicroRNA-34a; Breast cancer; Adriamycin; Notch1; Chemosensitivity
资金
- National Natural Science Foundation of China [81272470]
- Social Development Project of Jiangsu Province [BS2007077]
Background and Aims. MicroRNA-34a (miR-34a) as a tumor suppressor has been reported in many other studies. However, its role in modulating the sensitivity of breast cancer cells to adriamycin (ADR) remains unclear. The aim of this study is to evaluate the role of miR-34a in the sensitivity of breast cancer cells to ADR. Methods. The role of miR-34a in breast cancer cells was detected using MTT assay, flow cytometry assay, real-time PCR and Western blot, etc. The association of miR-34a and Notch1 was analyzed by dual-luciferase reporter assay and Notch1-siRNA technology. Real-time PCR assay was performed to test the expression of miR-34a and Notch] in 38 selective breast cancer tissue samples. Results. Ectopic overexpression of miR-34a could sensitize MCF-7 breast cancer cells to ADR. MiR-34a mimic could inhibit the luciferase activity of the construct containing wild-type 3 ' UTR of Notch1 in MCF-7/ADR cells. Notch1-siRNA could partially reverse the effect of miR-34a inhibitor in inducing chemoresistance of MCF-7 cells to ADR. Further, there was an inverse association between Notch1 and miR-34a expression in breast cancer. Conclusion. Dysregulation of miR-34a plays critical roles in the acquired ADR resistance of breast cancer, at least in part via targeting Notch1. (C) 2012 MISS. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据